Vendor source

Reviewed 11 May 2026

Completeness Strong (61%)

MR Image Analysis Software - MRI Cardiac

United Imaging Intelligence

The MRI Cardiac Analysis application is intended to provide a tool for segmenting, quantifying and evaluating MRI cardiac sequences including CINE, T1 Mapping, Perfusion, LGE and T2W.

No papers to support — we monitor for new evidence.

MR Image Analysis Software - MRI Cardiac thumbnail 1
MR Image Analysis Software - MRI Cardiac thumbnail 2
MR Image Analysis Software - MRI Cardiac thumbnail 3
MR Image Analysis Software - MRI Cardiac thumbnail 4
MR Image Analysis Software - MRI Cardiac thumbnail 5

Key Features

  • Contour and pseudocolor display
  • Graph of parameters
  • Segmentation of heart chambers (including ventricles)

General Information

Product name

MR Image Analysis Software - MRI Cardiac

Modality

MR

Main task

Quantification, Segmentation

Subspeciality

Cardiac

Disease targeted

Cardiomyopathy, cardiac amyloidosis, Fabry disease, myocardial fibrosis, myocardial edema, myocardial infarction, coronary artery disease

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Adult, Elderly

Input

Cardiac MRI images

Input format

DICOM

Output

Segmentation of left ventricle, Cardiac function/strain parameters, Bull's eye maps, ECV Map, Myocardium and blood pool parameters, SI Curve

Output format

Not specified

Integration

Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, docker)

Trigger for analysis

Automatically, right after the image acquisition

Processing time

Not specified

Population

Age 18–120; standalone use. Caution: not clinically validated for 1) cardiac pacemaker; 2) implantable cardioverter-defibrillator; 3) aneurysm clips; 4) nerve stimulators; 5) infusion pumps; 6) cochlear implants; 7) other conditions such as claustrophobia, ocular foreign bodies (especially metal), or unstable angina. Note: coronary stents are not a contraindication.

Market Presence

On market since

08-2025

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

One-time license fee, Pay-per-use, Subscription

Based on

Number of analyses, Number of installations, Number of users

Source: Vendor | First published: Oct 22, 2025 | Last updated: May 11, 2026